Effects of a German asthma disease management program using sickness fund claims data

Journal of Asthma

Volumn 47, Issue 6, 2010, Pages 674-679

  Windt, Roland ^a   Glaeske, Gerd ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Asthma; Claims data; Disease management; Germany; Matched cohort study

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; REPROTEROL; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FINANCIAL MANAGEMENT; GERMANY; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; GERMANY; HUMANS; INFANT; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SELF CARE; YOUNG ADULT;

EID: 77955536617     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770900903556421     Document Type: Article

References (22)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59:469-478.
2. Hoffmann F. Prevalence of asthma among German adults: analysis of the German National Telephone Survey. J Asthma 2007; 44:433-436.
3. Disease Management Association of America. DMAA Definition of Disease Management. Available at: http://www.dmaa.org/dm definition.asp. Last accessed August 8, 2009.
4. Schrappe M. Die Krankenhaus-Perspektive: Disease Management und sektorale Schnittstellen [The hospital perspective: disease management and integrated health care]. Z Arztl Fortbild Qualitatssich 2003; 97: 195-200.
5. IQWiG. Systematic guideline search and appraisal, as well as extraction of new and relevant recommendations, for the DMP "Asthma/COPD." Executive Summary. Available at: http://www.iqwig.de/download/V06-04 Executive summary DMP Asthma COPD.pdf. Last accessed August 12, 2009.
6. Bundesversicherungsamt. English Language Information. Available at: http://www.bundesversicherungsamt.de/cln 091/nn 1046648/DE/Service/ EnglishInformation/englishinformation node.html? nnn = true. Last accessed September 18, 2009.
7. Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano AJ, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ 2002; 325:925-932.
8. Bertelsmann Stiftung. Health Policy Monitor. Disease Management Programs-Time to Evaluate. Available at: http://www.hpm.org/en/ Surveys/TU Berlin - D/13/Disease Management Programs Time to evaluate.html. Last accessed September 18, 2009.
9. Himmel W, Hummers-Pradier E, Schumann H, Kochen MM. The predictive value of asthma medications to identify individuals with asthma-a study in German general practices. Br J Gen Pract 2001; 51:879-883.
10. Schatz M, Nakahiro R, Jones CH, Roth RM, Joshua A, Petitti D. Asthma population management: development and validation of a practical 3-level risk stratification scheme. Am J Manag Care 2004; 10:25-32.
11. Schatz M, Zeiger RS, Vollmer WM,Mosen D, Mendoza G, Apter AJ, et al. The controller-to-total asthma medication ratio is associated with patientcentered as well as utilization outcomes. Chest 2006; 130:43-50.
12. DAgostino RBJ. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281.
13. Rubin DB, ed. Matched Sampling for Causal Effects. Cambridge, UK: Cambridge University Press, 2006.
14. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008; 27:2037-2049.
15. Agresti A, Min Y. Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data. Stat Med 2004; 23:65-75.
16. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107:937-944. (Pubitemid 32523331)
17. Global Initiative for Asthma. Global strategy for asthma management and prevention 2008 (update). Available at: http://www.ginasthma.com/ Guidelineitem.aspl1 = 2&l2 = 1&intId = 1561. Last accessed October 22, 2009.
18. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15-26.
19. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthmarelated deaths. Ann Intern Med 2006; 144:904-912.
20. Schlette S, LisacM, Blum K. Integrated primary care in Germany: the road ahead. Int J Integr Care 2009; 9:e14.
21. Johnson A, Berg GD, Long J, Wadhwa S. A matched-cohort study of utilization outcomes for an adult medicaid population enrolled in an asthma diseasemanagement program. JAmbulCareManage 2007; 30:241-258.
22. Galbreath AD, Smith B, Wood PR, Inscore S, Forkner E, Vazquez M, et al. Assessing the value of disease management: impact of 2 disease management strategies in an underserved asthma population. Ann Allergy Asthma Immunol 2008; 101:599-607.